News & Updates

Retrospective study validates nirsevimab role against RSV in infants

A retrospective cohort study evaluating participants from Catalonia, Spain reinforces the potential of immunoprophylaxis with the novel monoclonal antibody nirsevimab in combating respiratory syncytial virus (RSV)-related outcomes in infants in the hospital and primary care settings.

Elevated BP and cerebral small vessel disease prevalent in HK’s middle-aged and older residents

According to local data presented at AIM 2024, approximately two-thirds of middle-aged and older residents in Hong Kong have systolic blood pressure (SBP) >120 mm Hg. A high prevalence of cerebral small vessel disease (SVD) is also found in this population.

BMI, ageing tied to adiposity

Age and BMI both have influence on adiposity, with varying effects depending on the type of adipose tissue (AT), suggests a study.

Antibiotic and antiviral therapy in COVID-19 patients: Updates from ESCMID Global 2024

In COVID-19 patients, antibiotic therapy should be reserved only for suspected bacterial superinfections.

However, international data from over 1 million hospitalized COVID-19 patients across 65 countries showed that antibiotics were commonly prescribed empirically despite the low rates of reported bacterial co-infection.¹

Novel cardiac myosin inhibitor helps with exercise capacity in obstructive HCM

Treatment with the oral selective cardiac myosin inhibitor aficamten produced improvements in peak oxygen uptake in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), as shown in the phase III SEQUOIA-HCM trial.